COPAXONE: payments to doctors
Payments that named COPAXONE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $317K
- Providers
- 139
- Transactions
- 377
- Average per transaction
- $841
The per-transaction average — $841 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 139 providers the average total is $2,281, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $317,102 | 100.0% |